论文部分内容阅读
在全国“两会”召开前夕,医药企业与价格管制部门之间的博弈、均衡的结果竟然转移到他们之外的“以药养医”机制的作用地——医院体系,耐人寻昧。
On the eve of the “NPC and CPPCC National Committee” held in the People’s Republic of China, the result of a balanced game between the pharmaceutical enterprises and the price control departments turned to the function of the “medicine-and-medicine-rearing” mechanism outside of them - the hospital system.